Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Smoking × Budesonide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Smoking 1 Multiple Myeloma 1 Leukemia, Plasma Cell 1

Interventions

Vitamin B 12 1 Folic Acid 1 Erlotinib Hydrochloride 1 Budesonide 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00321893 2016-01-25

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed

225 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡